Kidney Week

Oral Abstract Session

Late-Breaking Research Orals - 3

November 08, 2025 | 04:30 PM - 06:00 PM

Location: Grand Ballroom C, Convention Center

Session Description

Late-Breaking Research Orals - 3

Note: Continuing education credits are not being offered for this session.

Learning Pathway(s)

• Other

Moderators

• Krzysztof Kiryluk, MD
• Laura H. Mariani, MD, MS, FASN

Presentations

• Safety and Efficacy of Anti-CD19/B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor-Natural Killer Cell (CAR-NK) Therapy in Pediatric Patients with Refractory Systemic Lupus Erythematosus (SLE): A Preliminary Clinical Study
  04:30 PM - 04:42 PM
  
  • Hanyan Meng

Safety and Efficacy of Anti-CD19/B Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor-Natural Killer Cell (CAR-NK) Therapy in Pediatric Patients with Refractory Systemic Lupus Erythematosus (SLE): A Preliminary Clinical Study

November 08, 2025 | 04:30 PM - 04:42 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Farabursen Increases Urinary Polycystin-1 and Polycystin-2 and Reduces Height-Adjusted Total Kidney Volume Growth in Patients with ADPKD
  04:42 PM - 04:54 PM
  
  • Alan S.L. Yu, MBChB

Farabursen Increases Urinary Polycystin-1 and Polycystin-2 and Reduces Height-Adjusted Total Kidney Volume Growth in Patients with ADPKD

November 08, 2025 | 04:42 PM - 04:54 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Trial to Evaluate and Assess Effects of Comprehensive Kidney Replacement Therapy (KRT)-Directed, Pre-ESKD Education (CoPE) on Home Dialysis Among Veterans (TEACH-VET): Evaluating KRT Decision-Making State (KDS) Outcomes
  04:54 PM - 05:06 PM
  
  • Ashutosh M. Shukla, MD, FASN

Trial to Evaluate and Assess Effects of Comprehensive Kidney Replacement Therapy (KRT)-Directed, Pre-ESKD Education (CoPE) on Home Dialysis Among Veterans (TEACH-VET): Evaluating KRT Decision-Making State (KDS) Outcomes

November 08, 2025 | 04:54 PM - 05:06 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Efficacy and Safety of Povetacicept in Patients with IgAN and Primary Membranous Nephropathy (pMN) at 48 Weeks of Treatment: The RUBY-3 Study
  05:06 PM - 05:18 PM
  
  • James A. Tumlin, MD, FASN

Efficacy and Safety of Povetacicept in Patients with IgAN and Primary Membranous Nephropathy (pMN) at 48 Weeks of Treatment: The RUBY-3 Study

November 08, 2025 | 05:06 PM - 05:18 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Long-Term Effect of Oral Methylprednisolone on Kidney Outcomes in Patients with IgAN: TESTING-ON, a Post-Trial Observational Study
  05:18 PM - 05:30 PM
  
  • Muh Geot Wong, MBBS, PhD

Long-Term Effect of Oral Methylprednisolone on Kidney Outcomes in Patients with IgAN: TESTING-ON, a Post-Trial Observational Study

November 08, 2025 | 05:18 PM - 05:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• AHA/ACC Hypertension Guidelines: What's New for Kidney Diseases?
  05:30 PM - 06:00 PM
  
  • Vivek Bhalla, MD, FASN

AHA/ACC Hypertension Guidelines: What's New for Kidney Diseases?

November 08, 2025 | 05:30 PM - 06:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.